GTC Biotherapeutics (fka GTCB)

[keitern]

>>immense dilution<<

EV is only 60M here - c'mon. So this has gone from a near term bonanza to a near term low risk potential significant gainer. Then, one could hold on for solid appreciation over the years, IMO. This could still be a great stock and probably will. I don't see that much risk. GTCB's disclaimer that these protiens may be difficult to create in quantity seem to me to be in the slim to nothing category (but then I have to wait for my girls to get further in their medical career so they can teach me why).